Johann Hari: They’re Lying To You About The Side Effects Of Ozempic!
Author Johan Hari investigates the widespread adoption of GLP-1 agonists like Ozempic by spending a year using the drugs himself, revealing their profound neurological impact on brain reward systems alongside severe risks including muscle loss, pancreatitis, and high rates of weight regain upon cessation. The discussion highlights how these pharmaceuticals act as an artificial solution to an environment driven by ultra-processed foods, creating tension between treating obesity as a medical necessity and the potential for addiction transfer or societal misuse. While market projections suggest mass global usage by 2032 due to patent expirations and new formulations, experts caution that long-term metabolic and mental health effects remain largely unknown, necessitating a balance between individual risk assessment and broader systemic reforms to the food supply.